DavidRDobiesMDFACC FESC

Cardiology • Hot Springs, AR

Adult Congenital Heart Disease, Interventional Cardiology

Interventional Cardiologist

Join to view full profile

Dr. Dobies is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dobies' full profile

Already have an account?

Office
130 Medical Park Pl
Hot Springs, AR 71901
Phone+1 501-625-3400

Fax+1 501-625-3402
Is this information wrong?

Education & Training

University of OxfordEssential Medical Statistics and Executive Leadership, 2018 - 2019
Allegheny Health Network Medical Education Consortium (AGH)Fellowship, Interventional Cardiology, 1999 - 2000
Beaumont Health (Royal Oak)Fellowship, Cardiovascular Disease, 1996 - 1999
Indiana University School of MedicineResidency, Internal Medicine, 1993 - 1996
Community Health Network, Inc.Internship, Transitional Year, 1992 - 1993
Michigan State University College of Human MedicineClass of 1992

Certifications & Licensure

AR State Medical License 2021 - 2025
MI State Medical License 1996 - 2024
PA State Medical License 1999 - 2000
IN State Medical License 1993 - 1997
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Circulation Circulation: Cardiovascular Interventions Editors' Picks: A Selection of the Most Important Articles Published. Circulation 2011;124:161–9. doi:10.1161/circulationaha.111.049197 Lasala JM, Cox DA, Dob, 2011
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FACC) American College of Cardiology

Clinical Trials

IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103) Start of enrollment: 2005 Oct 17
Completed
Phase 3
TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions Start of enrollment: 2004 Aug 01
Completed
Phase 3
Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736) Start of enrollment: 2007 Dec 01
Terminated
Phase 3
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) Start of enrollment: 2007 Sep 01
Completed
Phase 2
TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance Program Start of enrollment: 2004 Feb 01
Completed
Phase 4
CRESTOR Athero Imaging Head to Head IVUS Study Start of enrollment: 2008 Jan 01
Completed
Phase 3
A Prospective Evaluation in a Randomized Trial of TAXUS in the Treatment of De Novo Coronary Artey Lesions
Unknown status
Phase 1
A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI Start of enrollment: 2008 Dec 01
Completed
Phase 2
AngelMed for Early Recognition and Treatment of STEMI Start of enrollment: 2008 Dec 01
Completed
Phase 3
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions Start of enrollment: 2009 Jan 01
Completed
Phase 3
Phase III Acute Coronary Syndrome Start of enrollment: 2009 Mar 01
Terminated
Phase 3
TAXUS Libertē Post Approval Study Start of enrollment: 2009 Dec 01
Completed
Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome Start of enrollment: 2010 Mar 01
Completed
Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) Start of enrollment: 2009 Aug 01
Unknown status
EXCEL Clinical Trial Start of enrollment: 2010 Sep 29
Completed
Not Applicable
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin Start of enrollment: 2010 Oct 01
Completed
Phase 3
Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries Start of enrollment: 2010 Dec 01
Completed
Not Applicable
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) Start of enrollment: 2012 Nov 01
Completed
Phase 3
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events Start of enrollment: 2013 Apr 25
Completed
Phase 3
A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI Start of enrollment: 2013 Sep 01
Terminated
Phase 3
Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study Start of enrollment: 2015 Dec 18
Completed
Phase 3
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency Start of enrollment: 2017 Mar 15
Completed
Phase 3
Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival Start of enrollment: 2016 Dec 01
Completed
Join now to see all

Publications & Presentations

PubMed

26 citations
Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study.
John A. Ormiston, Ehtisham Mahmud, Mark Turco, Jeffrey J. Popma, Neil J. Weissman, Louis Cannon, Tift Mann, Michael J. Lucca, Soo-Teik Lim, Jack J. Hall, Dougal McClea...> ;JACC. Cardiovascular Interventions. 2008 Apr 1
36 citations
Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry.
John M. Lasala, David A. Cox, David Dobies, Joseph B. Muhlestein, John N Katopodis, George Revtyak, Donald S. Baim, Arrive Participating Physicians> ;Catheterization and Cardiovascular Interventions. 2008 Oct 1
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro ...> ;JAMA.
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.
Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari...> ;JAMA.
4 citations
Feasibility and Utility of a Cardiovascular Risk Screening Tool in Women Undergoing Routine Gynecology Evaluation.
Jennifer Yu, Ki Park, Jaya Chandrasekhar, Deborah N. Kalkman, Jerri A Johnson, Robert A. Wild, David Dobies, Lynn Thomas, Kimberly A. Skelding, Bina Ahmed, Kimberly R ...> ;Journal of Women's Health. 2020 Jul 13
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Bov...> ;The New England journal of medicine. 2019-09-28
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P,...> ;The New England journal of medicine. 2018-11-10
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause...> ;The New England journal of medicine. 2018-11-10
1 citations
Critical appraisal of cardiology guidelines on revascularisation: clinical practice.
David Dobies, Kimberly R Barber> ;Open Heart. 2018 Feb 1
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, ...> ;The New England journal of medicine. 2016-10-31
9 citations
Analysis of safety outcomes for radial versus femoral access for percutaneous coronary intervention from a large clinical registry.
David Dobies, Kimberly R Barber, Amanda L Cohoon> ;Open Heart. 2016 Aug 1
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Re...> ;The New England journal of medicine. 2015-06-03
Long-term use of ticagrelor in patients with prior myocardial infarction.
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto...> ;The New England journal of medicine. 2015-03-14
3 citations
Validity of a PCI Bleeding Risk Score in patient subsets stratified for body mass index
David Dobies, Kimberly R Barber, Amanda L Cohoon> ;Open Heart. 2015 Feb 1
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR, Krucoff MW, Hermiller J, Dauerman HL, S...> ;The New England journal of medicine. 2014-11-16
2 citations
The effect of bivalirudin and closure device on bleeding outcomes after percutaneous coronary interventions
David Dobies, Kimberly R Barber, Amanda L Cohoon> ;Open Heart. 2014 Aug 1
10 citations
Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TL...
Ron Waksman, Magdi G.H. Ghali, Randy Goodroe, Thomas J. Ryan, Mark Turco, Michael E. Ring, Thomas F. McGarry, David Dobies, Nicolas Shammas, Daniel H. Steinberg, Stacy...> ;The American Journal of Cardiology. 2012 Oct 15
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM...> ;The New England journal of medicine. 2011-11-13
Apixaban with antiplatelet therapy after acute coronary syndrome.
Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansk...> ;The New England journal of medicine. 2011-07-24
A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-E...
Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD, PLATINUM Trial Investigators> ;Journal of the American College of Cardiology. 2011-04-04
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial.
Rao SV, Melloni C, Myles-Dimauro S, Broderick S, Kosinski AS, Kleiman NS, Dzavík V, Tanguay JF, Chandna H, Gammon R, Rivera E, Alexander JH, Fier I, Roach J, Becker RC...> ;Circulation. 2010-04-05
64 citations
Drug-Eluting Stent Thrombosis in Routine Clinical Practice: Two-Year Outcomes and Predictors From the TAXUS ARRIVE Registries
John M. Lasala, David A. Cox, David Dobies, Kenneth W. Baran, William Bachinsky, Edwin W. Rogers, Jeffrey A. Breall, David H. Lewis, Aijun Song, Ruth M. Starzyk, Steph...> ;Circulation. Cardiovascular Interventions. 2009 Jul 22
10 citations
Repair of a Perforated Pulmonary Artery Due to a Swan-Ganz Catheter Using Thrombin Injection
David R. Dobies, Amanda L Cohoon, Ashley A. Bates> ;Circulation. 2009 May 5
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW, SYNTAX ...> ;The New England journal of medicine. 2009-02-18
Injecting lubricant into the guiding catheter enables stent deployment.
David R. Dobies, Amanda L Cohoon> ;The Journal of Invasive Cardiology. 2006 May 1
Join now to see all

Abstracts/Posters

The Impact of Applying both a Critical Statistical and a Critical Clinical Appraisal to the Randomized Trials that form the Cardiology Revascularization Guidelines: Im...
Dobies DR and Barber KR, Evidence Live 2018 University of Oxford, London, England, 6/18/2018
Review of cardiology guidelines recommendations on revascularization: considerations for clinical practice
Dobies DR and Barber KR, ESC Congress 2016, Rome, Italy, 8/24/2017
Registry Based Comparison of Clinical and Safety Events by Catheterization Access Routes: Radial Versus Femoral Outcomes
Dobies DR, Cohoon AL, and Barber KR, European Society of Cardiology Congress 2015, London, England, 8/27/2015
Outcomes of Femoral versus Radial Access for Cardiac Catheterization
Dobies DR, Barber KR, and Cohoon AL, Abstracts of EuroPCR & AsiaPCR/Sing Live 2013, Paris, France, 5/21/2013
Outcomes Related to Closure Methods for Cardiac Catheterizations
Dobies DR, Cohoon AL, and Barber KR, European Society of Cardiology Congress 2012, Munich, Germany, 8/25/2012
Co-chair, Expert Panel on DES Safety, “Safety and Drug-eluting Stents: Four Years Later.”
David Dobies, European Society of Cardiology (ESC), Stockholm, Sweden, 8/28/2010
Gender Differences in Cardiac Management among 30,000 Patients with Acute Coronary Syndrome from a Community Hospital Registry
Dobies DR, Barber KR, Cohoon AL, Smith S, and Bates, A., EuroPCR 2010 Scientific Program, Paris, France, 5/24/2010
Physician / Hospital Alignment through the Co-management Agreement Model
Dobies DR, Silver M, Bonnette J, Barber KR, and Cohoon AL, International Forum on Quality and Safety Health Care 2010, Nice, France, 4/20/2010
Outcomes of Direct Injection of Intra-coronary Eptifibatide During Acute Myocardial Infarctions
Dobies DR, Barber KR, Cohoon AL, Kure CD, and Bates AA, 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Baltimore, Maryland, USA, 4/30/2008
TAXUS ARRIVE Registry: 1-year outcomes
Lasalla, Cox, and Dobies, TCT 9th Symposium, Orlando, Florida, USA, 4/2004
Join now to see all

Lectures

Critical Appraisal of Cardiology Guidelines on Revascularization: Clinical Practice
International Conference on Global Heart Disease; Paris, France - 7/8/2019
Gender differences in coronary vascular outcomes with bivalirudin versus heparin during primary coronary intervention
International Academy of Cardiology; Vancouver, Canada - 7/23/2013
Outcomes of Femoral versus Radial Access for Cardiac Catheterization
EuroPCR 2013; Paris, France - 5/22/2013
Predictors of stent thrombosis in real-world use of the TAXUS Express2 Paclitaxel-eluting stent: insights from the ARRIVE registry of 2 years
EuroPRC 2007; Barcelona, Spain - 5/22/2007
The Impact of Silent Ischemia of Cardiac Enzymes and Wall Motion in Patients Undergoing Aerobic Exercise
First International Congress of Heart Disease; Washington DC, USA - 5/1999
Mechanisms for Creatine Kinase Elevation in Coronary Artery Interventions: Angiographic Correlate
American Heart Association 71st Scientific Sessions; Dallas, Texas, USA - 11/8/1998
Mechanisms for Creatine Kinase Elevation in Coronary Artery Interventions: Angiographic Correlates
American College of Cardiology, Michigan Chapter; Traverse City, Michigan - 1997
Join now to see all

Press Mentions

Dobies, Talbert Join National Park Medical Center (Movers & Shakers)August 23rd, 2021
Interventional Cardiologist Joins HS Cardiology AssociatesAugust 9th, 2021
New District Trustees Elected for AMS BoardApril 25th, 2022